Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
University of Colorado, Denver
Clarity Pharmaceuticals Ltd
LaNova Medicines Limited
The First Affiliated Hospital of Guangzhou Medical University
Shandong Cancer Hospital and Institute
City of Hope Medical Center
Oslo University Hospital
Henan Cancer Hospital
Zhejiang Cancer Hospital
AIDS Malignancy Consortium
Eastern Cooperative Oncology Group
Vidac Pharma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
University of Chicago
AIDS Malignancy Consortium
University of Colorado, Denver
Wuhan University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Academic and Community Cancer Research United
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
British Columbia Cancer Agency
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Arizona
Seoul National University Hospital
Children's Hospital of Philadelphia
M.D. Anderson Cancer Center
Albert Einstein College of Medicine
South Egypt Cancer Institute
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The Cleveland Clinic
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Mayo Clinic
University of Miami
Alliance for Clinical Trials in Oncology
AIDS Malignancy Consortium
University of Alabama at Birmingham